openPR Logo
Press release

US Neurological Disorder Drugs Market Size, Industry Trends, Share and Forecast 2020-2026

11-09-2020 09:23 AM CET | Health & Medicine

Press release from: ORION MARKET RESEARCH

US Neurological Disorder Drugs Market Size, Industry Trends,

The US neurological disorder drugs market is anticipated to grow significantly over the forecast period (2020-2026). Rising cases of neurological disorders, geriatric population, and rapid advancement by the key players operating in the neurological disorder drugs landscape are some of the key factors that drive the growth of the US neurological disorder drugs industry.
Besides, frequent developments in healthcare and drug discovery are leading to the introduction of new drugs for the treatment of neurological diseases. Key authorities such as WHO, National Institutes of Health, and National Institute of Neurological Disorders and Stroke are taking productive steps that flares-up the research activities for the novel drug discovery. For instance, in August 2019, the National Center for Advancing Translational Sciences and National Institute of Neurological Disorders and Stroke invited researchers to conduct a study on rare neurological and neuromuscular disorders.

Request a Free Sample of our US Neurological Disorder Drugs Market: https://www.omrglobal.com/request-sample/us-neurological-disorder-drugs-market

Besides the presence of the key players such as Eli Lilly and Co., Merck & Co. Inc., and Pfizer Inc. are contributing to the growth of the US neurological disorder drugs market growth. Further, the well-established healthcare infrastructure and a significant rise in the population with the age group ranging between 18 and 64 are also driving the market growth. For instance, as per the US Census Bureau, the total population in the US was more than 325.7 million, of which 62% was constituted by 18-64 age group people.

A full Report of US Neurological Disorder Drugs Market is Available at: https://www.omrglobal.com/industry-reports/us-neurological-disorder-drugs-market

Market Coverage

• Market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Disorder Type
• Country Covered- US
• Competitive Landscape- Eli Lilly and Co., Merck & Co. Inc., Abbvie Inc., Apotex Inc., AstraZeneca Plc, Pfizer Inc., Biogen Inc., and Amgen Inc.

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

US Neurological Disorder Drugs Market – Segmentation

By Disorder Type

• Alzheimer’s Disease
• Parkinson’s Disease
• Multiple Sclerosis
• Huntington Disease
• Others

Company Profiles

• AbbVie Inc.
• ACADIA Pharmaceuticals Inc.
• ApotexInc.
• Allergan Plc
• Amgen Inc.
• AstraZeneca Plc
• Biogen Inc.
• Eli Lilly and Co.
• Merck & Co. Inc.
• Pfizer Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-neurological-disorder-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Neurological Disorder Drugs Market Size, Industry Trends, Share and Forecast 2020-2026 here

News-ID: 2183391 • Views:

More Releases from ORION MARKET RESEARCH

Underfloor Heating System Market to Witness Growth Acceleration by 2031/ Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
Underfloor Heating System Market to Witness Growth Acceleration by 2031/ Archer …
Rapid expansion in building and construction industry coupled with cohesive government regulations that are imposed for environmental-friendly construction has enabled the manufacturers towards the development of energy-efficient heating systems. Underfloor heating system are used to maintain temperatures at a desired level by using thermal energy that is passed through a moderately hot element. It offers low maintenance cost and thermal comfort; resulting in the demand for underfloor heating systems. Underfloor
Organic Soap Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2031 | EarthHero, LLC., Lush Ltd., Neal's Yard (Natural Remedies) Ltd., Procter & Gamble Ireland
Organic Soap Market is Likely to Increase at a Significantly High CAGR during Fo …
Organic Soap Market is anticipated to grow at a considerable CAGR of 7.9% during the forecast period. Rising consumer awareness regarding the benefits of soaps derived from organic and natural ingredients is one of the major factors adding to the growth of the market. The market is observing a shift in consumer preferences towards organic soaps as these products contain a mix of basic oils and other toxic-free natural
Watersports Suits Market Size, Share, Trends, Demand, Segments, Leading Companies and Forecast till 2031 / Aquanaut India , Bare Sportswear Corp. , Body Glove
Watersports Suits Market Size, Share, Trends, Demand, Segments, Leading Companie …
Watersports suits market is anticipated to grow at a CAGR of 5.3% during the forecast period. The global watersports suit market growth is driven by the factors such as the rising inclination of people towards numerous watersports activities which include wakeboarding, water skiing, scuba diving, and rising sports tournaments and recreational activities globally. Moreover, these suits are gaining immense popularity owing to their diversified applications in sea rescue and other
Diving Suits Market is Dazzling Worldwide and Forecast to 2031
Diving Suits Market is Dazzling Worldwide and Forecast to 2031
The global diving suits market is estimated to record a CAGR of 4.5% during the forecast period. The need to grow the market for outdoor-inspired apparel and other related equipment has been recognized by the industry with new initiatives unfolding on a regular basis aimed at stimulating consumer interest, particularly in the young population. The marine industry is witnessing an increasing appeal of technologically advanced features, such as joystick docking control, automatic

All 5 Releases


More Releases for Disorder

Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior. Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms
Autism Spectrum Disorder (ASD) Treatment Market Report 2018: Segmentation by Aut …
Global Autism Spectrum Disorder (ASD) Treatment market research report provides company profile for Roche Pharmaceuticals, Autism Treatment Plus, Fraser, Retrophin, Inc., Autism Services Inc., Pfizer Inc., SynapDx, Behavior Analysis, Inc., Autism Therapeutics, Curemark LLC and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,
Speech Therapy Service Market Report 2018: Segmentation by Product (Speech Disor …
Global Speech Therapy Service market research report provides company profile for Benchmark Therapies, Talk Speech, Language Therapy, Speech Plus, Smart Speech Therapy, Therapy Solutions, Glenda Browne Speech Pathology and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Somatostatin Receptor Market For Hormonal Disorder, Oncology, Metabolic Disorder
MarketResearchReports.Biz adds “Global Somatostatin Receptor Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Somatostatin Receptor and the growth estimates for the forecasted period. This report studies the Somatostatin Receptor Type 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of